Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial
Zhang, Li, Prof, Huang, Yan, MD, Hong, Shaodong, MD, Yang, Yunpeng, MD, Yu, Gengsheng, MD, Jia, Jun, MD, Peng, Peijian, MD, Wu, Xuan, MD, Lin, Qing, Prof, Xi, Xuping, Prof, Peng, Jiewen, MD, Xu, Mingjun, MD, Chen, Dongping, Prof, Lu, Xiaojun, MD, Wang, Rensheng, MD, Cao, Xiaolong, MD, Chen, Xiaozhong, MD, Lin, Zhixiong, Prof, Xiong, Jianping, MD, Lin, Qin, MD, Xie, Conghua, MD, Li, Zhihua, MD, Pan, Jianji, Prof, Li, Jingao, MD, Wu, Shixiu, Prof, Lian, Yingni, MD, Yang, Quanlie, MD, Zhao, Chong, Prof
Published in The Lancet (British edition) (15.10.2016)
Published in The Lancet (British edition) (15.10.2016)
Get full text
Journal Article
Prognostic significance of circulating tumor cell measurement in the peripheral blood of patients with nasopharyngeal carcinoma
Gao, Tinghua, Mao, Jinxing, Huang, Jindu, Luo, Fengling, Lin, Lixiang, Lian, Yingni, Bin, Sanmei, Zhao, Lianghua, Li, Shuping
Published in Clinics (São Paulo, Brazil) (01.01.2023)
Published in Clinics (São Paulo, Brazil) (01.01.2023)
Get full text
Journal Article
Gemcitabine Plus Cisplatin Versus Fluorouracil Plus Cisplatin as First-Line Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: Final Overall Survival Analysis of GEM20110714 Phase III Study
Hong, Shaodong, Zhang, Yaxiong, Yu, Gengsheng, Peng, Peijian, Peng, Jiewen, Jia, Jun, Wu, Xuan, Huang, Yan, Yang, Yunpeng, Lin, Qing, Xi, Xuping, Xu, Mingjun, Chen, Dongping, Lu, Xiaojun, Wang, Rensheng, Cao, Xiaolong, Chen, Xiaozhong, Lin, Zhixiong, Xiong, Jianping, Lin, Qin, Xie, Conghua, Li, Zhihua, Pan, Jianji, Li, Jingao, Wu, Shixiu, Lian, Yingni, Yang, Quanlie, Zhao, Chong, Fang, Wenfeng, Zhang, Li
Published in Journal of clinical oncology (10.10.2021)
Published in Journal of clinical oncology (10.10.2021)
Get full text
Journal Article